Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Post-marketing, Observational Study of Rituxan in Rheumatoid Arthritis Patients in Routine Clinical Practice

NCT00984711 is registered in ClinicalTrials.gov with PerCuro Clinical Research Ltd as lead sponsor.

NCT NCT00984711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00984711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Post-marketing, Observational Study of Rituxan in Rheumatoid Arthritis Patients in Routine Clinical Practice
Lead sponsor
PerCuro Clinical Research Ltd
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2007
Completion date
December 31, 2015
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis